Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-16-596034
Filing Date
2016-05-19
Accepted
2016-05-19 16:08:03
Documents
5
Period of Report
2016-05-19

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d113154d6k.htm 6-K 10916
2 EX-99.1 d113154dex991.htm EX-99.1 151472
3 EX-99.2 d113154dex992.htm EX-99.2 65605
4 EX-99.3 d113154dex993.htm EX-99.3 55270
5 GRAPHIC g113154g76s97.jpg GRAPHIC 10614
  Complete submission text file 0001193125-16-596034.txt   298982
Mailing Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900 45 36 94 44 86
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 161663285
SIC: 2834 Pharmaceutical Preparations